awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50910928-497A9EC6-8E5E-40E7-8FC2-463CB5448622
Q50910928-497A9EC6-8E5E-40E7-8FC2-463CB5448622
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50910928-497A9EC6-8E5E-40E7-8FC2-463CB5448622
How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The itsy bitsy anemia problem.
P2860
Q50910928-497A9EC6-8E5E-40E7-8FC2-463CB5448622
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50910928-497A9EC6-8E5E-40E7-8FC2-463CB5448622
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
71cadfbdda0cdceead9d158ca3ab87018f4d069a
P2860
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.